Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Huntingtons Disease Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Psychotherapy
1.2.3 Medical Treatement
1.2.4 Others
1.3 Market by Application
1.3.1 Global Huntingtons Disease Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Huntingtons Disease Therapeutics Market Perspective (2018-2033)
2.2 Huntingtons Disease Therapeutics Growth Trends by Region
2.2.1 Global Huntingtons Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Huntingtons Disease Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Huntingtons Disease Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Huntingtons Disease Therapeutics Market Dynamics
2.3.1 Huntingtons Disease Therapeutics Industry Trends
2.3.2 Huntingtons Disease Therapeutics Market Drivers
2.3.3 Huntingtons Disease Therapeutics Market Challenges
2.3.4 Huntingtons Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Huntingtons Disease Therapeutics Players by Revenue
3.1.1 Global Top Huntingtons Disease Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Huntingtons Disease Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Huntingtons Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Huntingtons Disease Therapeutics Revenue
3.4 Global Huntingtons Disease Therapeutics Market Concentration Ratio
3.4.1 Global Huntingtons Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Huntingtons Disease Therapeutics Revenue in 2022
3.5 Huntingtons Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Huntingtons Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Huntingtons Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Huntingtons Disease Therapeutics Breakdown Data by Type
4.1 Global Huntingtons Disease Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Huntingtons Disease Therapeutics Forecasted Market Size by Type (2024-2033)
5 Huntingtons Disease Therapeutics Breakdown Data by Application
5.1 Global Huntingtons Disease Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Huntingtons Disease Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Huntingtons Disease Therapeutics Market Size (2018-2033)
6.2 North America Huntingtons Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Huntingtons Disease Therapeutics Market Size by Country (2018-2023)
6.4 North America Huntingtons Disease Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Huntingtons Disease Therapeutics Market Size (2018-2033)
7.2 Europe Huntingtons Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Huntingtons Disease Therapeutics Market Size by Country (2018-2023)
7.4 Europe Huntingtons Disease Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Huntingtons Disease Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Huntingtons Disease Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Huntingtons Disease Therapeutics Market Size (2018-2033)
9.2 Latin America Huntingtons Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Huntingtons Disease Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Huntingtons Disease Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Huntingtons Disease Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Huntingtons Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ValeantPharmaceuticals International lnc.
11.1.1 ValeantPharmaceuticals International lnc. Company Detail
11.1.2 ValeantPharmaceuticals International lnc. Business Overview
11.1.3 ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Introduction
11.1.4 ValeantPharmaceuticals International lnc. Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.1.5 ValeantPharmaceuticals International lnc. Recent Development
11.2 Alnylam Pharmaceuticals Inc.
11.2.1 Alnylam Pharmaceuticals Inc. Company Detail
11.2.2 Alnylam Pharmaceuticals Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Introduction
11.2.4 Alnylam Pharmaceuticals Inc. Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.2.5 Alnylam Pharmaceuticals Inc. Recent Development
11.3 AmpliPhi Biosciences Corp
11.3.1 AmpliPhi Biosciences Corp Company Detail
11.3.2 AmpliPhi Biosciences Corp Business Overview
11.3.3 AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Introduction
11.3.4 AmpliPhi Biosciences Corp Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.3.5 AmpliPhi Biosciences Corp Recent Development
11.4 Ceregene Inc.Lundbeck
11.4.1 Ceregene Inc.Lundbeck Company Detail
11.4.2 Ceregene Inc.Lundbeck Business Overview
11.4.3 Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Introduction
11.4.4 Ceregene Inc.Lundbeck Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.4.5 Ceregene Inc.Lundbeck Recent Development
11.5 Prana Biotechnology Limited
11.5.1 Prana Biotechnology Limited Company Detail
11.5.2 Prana Biotechnology Limited Business Overview
11.5.3 Prana Biotechnology Limited Huntingtons Disease Therapeutics Introduction
11.5.4 Prana Biotechnology Limited Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.5.5 Prana Biotechnology Limited Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 Cortex Pharmaceuticals lnc.
11.7.1 Cortex Pharmaceuticals lnc. Company Detail
11.7.2 Cortex Pharmaceuticals lnc. Business Overview
11.7.3 Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Introduction
11.7.4 Cortex Pharmaceuticals lnc. Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.7.5 Cortex Pharmaceuticals lnc. Recent Development
11.8 VertexPharmaceuticals Incorporated
11.8.1 VertexPharmaceuticals Incorporated Company Detail
11.8.2 VertexPharmaceuticals Incorporated Business Overview
11.8.3 VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Introduction
11.8.4 VertexPharmaceuticals Incorporated Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.8.5 VertexPharmaceuticals Incorporated Recent Development
11.9 Auspex Pharmaceuticals
11.9.1 Auspex Pharmaceuticals Company Detail
11.9.2 Auspex Pharmaceuticals Business Overview
11.9.3 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Introduction
11.9.4 Auspex Pharmaceuticals Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.9.5 Auspex Pharmaceuticals Recent Development
11.10 SOM Biotech
11.10.1 SOM Biotech Company Detail
11.10.2 SOM Biotech Business Overview
11.10.3 SOM Biotech Huntingtons Disease Therapeutics Introduction
11.10.4 SOM Biotech Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.10.5 SOM Biotech Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Huntingtons Disease Therapeutics Introduction
11.11.4 GlaxoSmithKline Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.11.5 GlaxoSmithKline Recent Development
11.12 Siena Biotech
11.12.1 Siena Biotech Company Detail
11.12.2 Siena Biotech Business Overview
11.12.3 Siena Biotech Huntingtons Disease Therapeutics Introduction
11.12.4 Siena Biotech Revenue in Huntingtons Disease Therapeutics Business (2018-2023)
11.12.5 Siena Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Huntingtons Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Psychotherapy
Table 3. Key Players of Medical Treatement
Table 4. Key Players of Others
Table 5. Global Huntingtons Disease Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Huntingtons Disease Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Huntingtons Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Huntingtons Disease Therapeutics Market Share by Region (2018-2023)
Table 9. Global Huntingtons Disease Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Huntingtons Disease Therapeutics Market Share by Region (2024-2033)
Table 11. Huntingtons Disease Therapeutics Market Trends
Table 12. Huntingtons Disease Therapeutics Market Drivers
Table 13. Huntingtons Disease Therapeutics Market Challenges
Table 14. Huntingtons Disease Therapeutics Market Restraints
Table 15. Global Huntingtons Disease Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Huntingtons Disease Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Huntingtons Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntingtons Disease Therapeutics as of 2022)
Table 18. Ranking of Global Top Huntingtons Disease Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Huntingtons Disease Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Huntingtons Disease Therapeutics Product Solution and Service
Table 22. Date of Enter into Huntingtons Disease Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Huntingtons Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Huntingtons Disease Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Huntingtons Disease Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Huntingtons Disease Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Huntingtons Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Huntingtons Disease Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global Huntingtons Disease Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Huntingtons Disease Therapeutics Revenue Market Share by Application (2024-2033)
Table 32. North America Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Huntingtons Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Huntingtons Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Huntingtons Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Huntingtons Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Huntingtons Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Huntingtons Disease Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Huntingtons Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Huntingtons Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Huntingtons Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Huntingtons Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. ValeantPharmaceuticals International lnc. Company Detail
Table 48. ValeantPharmaceuticals International lnc. Business Overview
Table 49. ValeantPharmaceuticals International lnc. Huntingtons Disease Therapeutics Product
Table 50. ValeantPharmaceuticals International lnc. Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 51. ValeantPharmaceuticals International lnc. Recent Development
Table 52. Alnylam Pharmaceuticals Inc. Company Detail
Table 53. Alnylam Pharmaceuticals Inc. Business Overview
Table 54. Alnylam Pharmaceuticals Inc. Huntingtons Disease Therapeutics Product
Table 55. Alnylam Pharmaceuticals Inc. Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Alnylam Pharmaceuticals Inc. Recent Development
Table 57. AmpliPhi Biosciences Corp Company Detail
Table 58. AmpliPhi Biosciences Corp Business Overview
Table 59. AmpliPhi Biosciences Corp Huntingtons Disease Therapeutics Product
Table 60. AmpliPhi Biosciences Corp Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 61. AmpliPhi Biosciences Corp Recent Development
Table 62. Ceregene Inc.Lundbeck Company Detail
Table 63. Ceregene Inc.Lundbeck Business Overview
Table 64. Ceregene Inc.Lundbeck Huntingtons Disease Therapeutics Product
Table 65. Ceregene Inc.Lundbeck Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Ceregene Inc.Lundbeck Recent Development
Table 67. Prana Biotechnology Limited Company Detail
Table 68. Prana Biotechnology Limited Business Overview
Table 69. Prana Biotechnology Limited Huntingtons Disease Therapeutics Product
Table 70. Prana Biotechnology Limited Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Prana Biotechnology Limited Recent Development
Table 72. Teva Pharmaceutical Industries Ltd. Company Detail
Table 73. Teva Pharmaceutical Industries Ltd. Business Overview
Table 74. Teva Pharmaceutical Industries Ltd. Huntingtons Disease Therapeutics Product
Table 75. Teva Pharmaceutical Industries Ltd. Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Teva Pharmaceutical Industries Ltd. Recent Development
Table 77. Cortex Pharmaceuticals lnc. Company Detail
Table 78. Cortex Pharmaceuticals lnc. Business Overview
Table 79. Cortex Pharmaceuticals lnc. Huntingtons Disease Therapeutics Product
Table 80. Cortex Pharmaceuticals lnc. Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Cortex Pharmaceuticals lnc. Recent Development
Table 82. VertexPharmaceuticals Incorporated Company Detail
Table 83. VertexPharmaceuticals Incorporated Business Overview
Table 84. VertexPharmaceuticals Incorporated Huntingtons Disease Therapeutics Product
Table 85. VertexPharmaceuticals Incorporated Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 86. VertexPharmaceuticals Incorporated Recent Development
Table 87. Auspex Pharmaceuticals Company Detail
Table 88. Auspex Pharmaceuticals Business Overview
Table 89. Auspex Pharmaceuticals Huntingtons Disease Therapeutics Product
Table 90. Auspex Pharmaceuticals Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Auspex Pharmaceuticals Recent Development
Table 92. SOM Biotech Company Detail
Table 93. SOM Biotech Business Overview
Table 94. SOM Biotech Huntingtons Disease Therapeutics Product
Table 95. SOM Biotech Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 96. SOM Biotech Recent Development
Table 97. GlaxoSmithKline Company Detail
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Huntingtons Disease Therapeutics Product
Table 100. GlaxoSmithKline Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 101. GlaxoSmithKline Recent Development
Table 102. Siena Biotech Company Detail
Table 103. Siena Biotech Business Overview
Table 104. Siena Biotech Huntingtons Disease Therapeutics Product
Table 105. Siena Biotech Revenue in Huntingtons Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 106. Siena Biotech Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Huntingtons Disease Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Huntingtons Disease Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Psychotherapy Features
Figure 4. Medical Treatement Features
Figure 5. Others Features
Figure 6. Global Huntingtons Disease Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Huntingtons Disease Therapeutics Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Huntingtons Disease Therapeutics Report Years Considered
Figure 12. Global Huntingtons Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Huntingtons Disease Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Huntingtons Disease Therapeutics Market Share by Region: 2022 VS 2033
Figure 15. Global Huntingtons Disease Therapeutics Market Share by Players in 2022
Figure 16. Global Top Huntingtons Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Huntingtons Disease Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Huntingtons Disease Therapeutics Revenue in 2022
Figure 18. North America Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Huntingtons Disease Therapeutics Market Share by Country (2018-2033)
Figure 20. United States Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Huntingtons Disease Therapeutics Market Share by Country (2018-2033)
Figure 24. Germany Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Huntingtons Disease Therapeutics Market Share by Region (2018-2033)
Figure 32. China Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Huntingtons Disease Therapeutics Market Share by Country (2018-2033)
Figure 40. Mexico Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Huntingtons Disease Therapeutics Market Share by Country (2018-2033)
Figure 44. Turkey Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Huntingtons Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. ValeantPharmaceuticals International lnc. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 47. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 48. AmpliPhi Biosciences Corp Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 49. Ceregene Inc.Lundbeck Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 50. Prana Biotechnology Limited Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 51. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 52. Cortex Pharmaceuticals lnc. Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 53. VertexPharmaceuticals Incorporated Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 54. Auspex Pharmaceuticals Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 55. SOM Biotech Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 57. Siena Biotech Revenue Growth Rate in Huntingtons Disease Therapeutics Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed